Bladder cancer patients
| Patient number N (%) | ||||
|---|---|---|---|---|
| Total | qPCR analysis | ELISA analysis | Chemotaxis | |
| Patients | 23(100) | 20(100) | 11(100) | 3(100) |
| Male | 15(65) | 14(70) | 6(55) | 1(33) |
| Female | 8(35) | 6(30) | 5(45) | 2(67) |
| Tumor stage: | ||||
| Stage 0 | 4(17) | 4(20) | 2(18) | |
| Stage 0is | 1(4) | 1(5) | ||
| Stage 1 | 6(26) | 5(25) | 3(27) | 1(33) |
| Stage 2 | 2(9) | 2(10) | 1(9) | |
| Stage 3 | 8(35) | 6(30) | 4(36) | 2(67) |
| Stage 4 | 2(9) | 2(10) | 1(9) | |
| Prior treatment: | ||||
| None | 15(65) | 13(65) | 7(64) | 2(67) |
| BCG | 5(22) | 5(25) | 2(18) | |
| Other treatment | 3(13) | 2(10) | 2(18) | 1(33) |